Amrize AG AMRZ ← Back to all reports

Amrize AG

AMRZ · Materials
B ★★★ Hold
Aug 9, 2026 · Score 76 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $46.64
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $44.00 ($42.00–$46.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $56.00
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative figure isn't an error. For richly valued stocks, the fair-value target can sit below the current price, so the return reads negative. The grade reflects company quality; this figure reflects today's entry valuation.
Methodology →
+20.1%

Type A - Amrize AG (AMRZ) 20260809 Stock Analysis

📅 Amrize Key Upcoming Events

🏢 Step 1: Amrize Company Overview & Business Model

Q1-A1. What is Amrize?

Q1-A2. How Does Amrize Make Money?

Q1-A3. Amrize’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Amrize’s Competitors?

Q1-A5. Amrize Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Amrize’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Amrize Have a Durable Economic Moat?

Q2-A2. Is Amrize’s Growth Sustainable?

Q2-A3. How Does Amrize Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Amrize Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Amrize? (Margins & ROIC)

Q3-A3. What Drives Amrize’s Returns? (ROIC Breakdown)

Q3-A4. Are Amrize’s Earnings High Quality?

Q3-A5. Is Amrize’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Amrize Forensic Accounting & Dilution Review

Q4-A1. Does Amrize Have Accounting Red Flags?

Q4-A2. Is Amrize Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Amrize’s Cash Flow?

Q4-A4. Is Amrize Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Amrize Management & Shareholder Alignment

Q5-A1. Can You Trust Amrize’s Management? (Guidance Track Record)

Q5-A2. What Are Amrize Insiders Doing?

Q5-A3. Is Amrize’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Amrize Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Amrize Guidance

Q6-A2. What Is Amrize’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Amrize Catalysts & Price Triggers

Q7-A1. What Could Move Amrize Stock? (Top 3 Catalysts)

Q7-A2. Amrize’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Amrize Fairly Valued? Valuation Analysis

Q8-A1. Amrize’s Key Valuation Multiples (P/E, EV/EBITDA)

Q8-A2. Amrize vs Peers: Valuation Comparison

Q8-A3. Is Amrize Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Amrize? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From Amrize? (Reverse DCF Alternative)

Q8-A5. Valuation Cross-Check

Q8-A6. Amrize’s Hidden Asset & Stake Valuation

Q8-A7. Final Valuation Adjustment

Q8-A8. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Amrize? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Amrize?

Q9-A2. How Sensitive Is Amrize to the Economy?

Q9-A3. Amrize Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: Amrize Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Amrize? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Amrize’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Amrize’s Heavy Exposure to Oil-Driven Freight Costs Its Biggest Weakness?

Q2: Can Amrize’s 18.3x Forward P/E Be Justified by the Infrastructure Supercycle?

Q3: Will the Push into Data Center and Mega-Project Construction Sustain Volume Growth?

Q4: How Effective Is the ASPIRE Cost Savings Program in Mitigating Inflation?

Q5: Does the Texas Roll-Up Strategy (PB Materials & Rapid Redi-Mix) Carry Severe Execution Risk?

Q6: Can the Building Envelope Segment Rebound Despite Residential Housing Softness?

Q7: Will the $600 Million U.S. Cement Expansion Create Catastrophic Oversupply Risks?

Q8: How Does Amrize’s Independence from Holcim Alter Its Long-Term Capital Allocation Profile?

Q9: Are the H2 2026 Sequential Price Hikes Sufficient to Restore EBITDA Margins by Year-End?

Q10: What Impact Will the Revised 23-25% Effective Tax Rate Have on Long-Term Free Cash Flow?

Rating History

Rating History shows the Rating assigned on each report date. We leave scores out of the timeline because reports from different periods may follow different rating scales. The score remains visible in each report that is still available.

  1. 2026-07 A
  2. 2026-08 B